NLM Digital Collections

Search

Start Over Authors Fluetsch, Noemi, author ✖Remove constraint Authors: Fluetsch, Noemi, author

1. Betibeglogene autotemcel for beta thalassemia: effectiveness and value : final evidence report

Author(s):
Beaudoin, Francesca L., author
Richardson, Marina, author
Synnott, Patricia G., author
Lancaster, Victoria, author
Fluetsch, Noemi, author
Herce-Hagiwara, Belén, author
Campbell, Jon D., author
Pearson, Steven D., author
Rind, David M., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, July 19, 2022
Subject(s):
beta-Thalassemia -- therapy
Biological Products -- therapeutic use
Genetic Therapy
United States

2. Special assessment of outpatient treatments for COVID-19: final evidence report and meeting summary

Author(s):
Yeung, Kai, 1981- author
Whittington, Melanie D., author
Beinfeld, Molly, author
Mohammed, Rasheed, author
Wright, Abigail, (Of Institute for Clinical and Economic Review), author
Nhan, Emily, author
Fluetsch, Noemi, author
Richardson, Marina, (Of Institute for Clinical and Economic Review), author
Pearson, Steven D., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, May 10, 2022
Subject(s):
Ambulatory Care
COVID-19 Drug Treatment
Home Infusion Therapy
United States

3. Digital health technologies as an adjunct to medication assisted therapy for opioid use disorder: final evidence report and meeting summary

Author(s):
Tice, Jeffrey A., author
Whittington, Melanie D., author
Fluetsch, Noemi, author
Zapata, Lorenzo Villa, author
Mendola, Nicolas D., author
Chapman, Rick M., author
Campbell, Jonathan D., author
Pearson, Steven D., author
Bradt, Pamela, author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, December 11, 2020
Subject(s):
Behavior Therapy
Digital Technology
Opiate Substitution Treatment
Opioid-Related Disorders -- therapy
United States

4. Esketamine for the treatment of treatment-resistant depression: effectiveness and value : final evidence report

Author(s):
Atlas, Steven, author
Agboola, Foluso, author
Fazioli, Katherine, author
Fluetsch, Noemi, author
Kumar, Varun, author
O'Grady, Madeline, author
Rind, David, author
Pearson, Steve, author
Touchette, Daniel R., author
Boyer, Nicole, author
Talon, Brian, author
Schultz, Bob G., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, June 20, 2019
Subject(s):
Depressive Disorder, Treatment-Resistant -- drug therapy
Hallucinogens -- therapeutic use
United States

6. Tezepelumab for severe asthma: final report

Author(s):
Rind, David M., author
Campbell, Jonathan D., author
Herce-Hagiwara, Belén, author
Herron-Smith, Serina, author
Fluetsch, Noemi, author
Pearson, Steven D., author
McQueen, R. Brett, author
Gutierrez, Eric, (Of University of Colorado), author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, February 13, 2023
Subject(s):
Antibodies, Monoclonal, Humanized -- therapeutic use
Asthma -- drug therapy
United States

7. Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pre-treated relapsed and refractory multiple myeloma: final report

Author(s):
Lee, Sei J., author
Beinfeld, Molly, author
Fluetsch, Noemi, author
Whittington, Melanie, D., author
Pearson, Steven D., author
Ollendorf, Daniel A., author
McQueen, R. Brett, author
Gutierrez, Eric, (Of University of Colorado Anschutz Medical Campus), author
Kwon, Sue, (Of University of Colorado Anschutz Medical Campus), author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, November 22, 2022
Subject(s):
Immunoconjugates -- therapeutic use
Immunotherapy, Adoptive
Multiple Myeloma -- drug therapy
United States